View Cart (0 items)

Pharmaceutical

Pfizer to pay $3.3 million to settle antibiotic marketing case

March 21, 2012
SALEM, Ore. — Pfizer Inc. has agreed to pay the state of Oregon more than $3.3 million to settle claims that the company used misleading statements and studies to
Read More

Feds demand $1.8 billion from J&J to resolve Risperdal civil claims

March 13, 2012
WASHINGTON — The U.S. government has demanded that Johnson & Johnson raise its offer by $800 million from an initial proposal to settle a federal civil investigation into marketing
Read More

Pfizer sues Johnson & Johnson for patent infringement

March 6, 2012
NEW YORK — Pfizer Inc. is seeking unspecified damages in a patent infringement lawsuit against a unit of Johnson & Johnson over pain-relieving heat-patch technology, Bloomberg reported. Fort Washington,
Read More

Eight arrested at Pfizer plant

March 1, 2012
GROTON, Conn. — Eight protesters were arrested Wednesday outside the main gate of Pfizer Inc. in Groton, Conn., when they allegedly crossed police lines and refused to leave the
Read More

Report delivers ROI analysis on key lifecycle management strategies used in pharmaceutical industry

February 28, 2012
CHAPEL HILL, N.C. — Strategies to extend the commercial life of mature brands are critical to today''s pharmaceutical industry. Used correctly, lifecycle management strategies can add as many as
Read More

Johnson & Johnson names new CEO

February 22, 2012
TRENTON, N.J. — Johnson & Johnson has named Alex Gorsky as CEO, effective April 26, according to a press release. Gorsky will succeed Bill Weldon, who has served as
Read More

J&J recalls 574,000 bottles of infant Tylenol

February 21, 2012
FORT WASHINGTON, Pa. — Johnson & Johnson’s McNeil Consumer Healthcare unit is voluntarily recalling approximately 574,000 bottles of infant Tylenol due to complaints about the SimpleMeasure™ dosing system, according
Read More

Pfizer advocates experimental Alzheimer’s drug

February 15, 2012
NEW YORK — Speaking at an investor conference in New York on Tuesday, Pfizer Inc. research chief Mikael Dolsten said the company’s experimental treatment for Alzheimer''s disease is the
Read More

Smith & Nephew pays $22 million to settle bribery claims, cuts 800 jobs

February 7, 2012
MEMPHIS, Tenn. — Medical device manufacturer Smith & Nephew announced Monday that it will pay $22 million to settle claims that it won business in Greece by bribing doctors,
Read More

GlaxoSmithKline to settle 20,000 more lawsuits over diabetes drug

February 2, 2012
BRENTFORD, UK — The UK’s biggest drugmaker GlaxoSmithKline Plc has agreed to settle 20,000 more lawsuits alleging its diabetes medication Avandia caused heart attacks, Bloomberg reported. The company has
Read More